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MODULATION BY STATIC MAGNETISM OF NEURONAL ACTIVITY
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In neurons, the signal propagation involves both the conduction mediated by local electric currents through voltage-sensitive 
cation channels in axons and the transmission mediated by the exocytotic release of neurotransmitters from nerve endings into 
synaptic clefts. A great number of desperate efforts have been dedicated to biochemical, pharmacological and molecular bio-
logical studies on the elucidation of mechanisms underlying the neurotransmission at synapses, while relatively little attention 
has been paid to the comprehensive evaluation of the conduction except for local anesthetics. According to a physical theo-
rem, exposure to magnetism should lead to the generation of a certain mechanical force in neurons with concomitant electric 
currents in a particular situation. In particular, repetitive transcranial magnetic stimulation is beneficial for the treatment of
selected patients suffering from depression, bipolar affective disorder and schizophrenia as a possible alternative to the elec-
troconvulsive therapy for refractory depression. In this review, therefore, we will summarize our recent advances made on the 
neurochemical and molecular biological elucidation in cultured rat hippocampal neurons toward better understanding by the 
readers of different disciplines of mechanisms associated with the modulation by magnetism of the neuronal activity in the brain. 
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INTRODUCTION
The signal propagation is believed to involve both the signal 
transmission mediated by the exocytotic release of a variety 
of neurotransmitters from nerve endings into synaptic clefts 
and the signal conduction mediated by local electric currents 
through voltage sensitive cation channels at axons in the 
mammalian central and peripheral nervous systems. Com-
pared to the number of biochemical, pharmacological and 
molecular biological studies dedicated to the elucidation of 
mechanisms underlying the neurotransmission at synapses, 
relatively little attention has been paid to mechanisms associ-
ated with the modulation of signal conduction by endogenous 
and exogenous stimuli. In the central nervous system (CNS), 
both oscillatory and static magnetic fields could modulate a
variety of cellular functions in glia as well as neurons through 
the electromagnetic induction and/or the mechanical force at 
biomembranes in vivo and in vitro (1). Strong static magnetic 
fields are proposed to modulate synaptic functions through the
altered diamagnetic anisotropy in membranes in the CNS and 
neuromuscular junctions (2). Furthermore, it is noteworthy 
that the ferromagnetic mineral magnetite is really present in 
different human tissues including brain (3,4).
In cultured GH3 cells, exposure to a 120 mT static magnetic 
field results in inhibition of the activity of voltage-activated
calcium channels on whole-cell patch clamp analysis (5). 
Brief exposure to static magnetic fields at 200 mT not only
leads to marked morphological alterations, but also results in 
a significant reduction of both thymidine incorporation and
inositol lipid signaling, in the human neuronal cell line FNC-
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B4 (6). Action potentials are blocked by static magnetic fields
in cultured sensory neurons (7), while alternating magnetic 
fields increase the expression of the glial marker protein glial 
fibrillary acidic protein (GFAP) in cultured astrocytes (8). An
immunohistochemical study shows that marked expression of 
c-Fos protein is induced by exposure for 30 min to magnetic 
fields at 9.4 T in the visceral and vestibular nuclei of rat brain
stem in vivo (9). In organotypic brain slices of rat parietal 
cortex, magnetic stimulation results in transient expression of 
c-Fos protein in neurons but not in astroglia via tetrodotoxin-
sensitive sodium channels 3 to 6 h after stimulation (10). Simi-
larly marked expression is shown with c-Fos protein in parietal 
cortex and hippocampus (11) as well as other telencephalic 
regions including the frontal cortex, striatum, dentate gyrus, 
Ammon’s horn and amygdala (12) after several sessions of 
repetitive transcranial magnetic stimulation (rTMS). 
Transcranial magnetic stimulation has been used as a di-
agnostic tool in neurobiological fields due to its painless and
noninvasive properties (13). In clinical studies, moreover, 
rTMS is shown to be beneficial for the treatment and therapy
of selected patients with depression, bipolar affective disorder 
and schizophrenia as a possible alternative to electroconvul-
sive therapy (ECT) that is often used for the treatment of 
refractory depression (14-16). The efficacy of weak magnetic
fields in the treatment of Parkinsonism and motor complica-
tions of chronic levodopa therapy is also proposed (17). In 
healthy subjects, however, rTMS is shown to induce transient 
mood enhancement (18,19). 
On the other hand, c-Fos protein family is a partner of c-Jun 
protein family members to compose the nuclear transcrip-
tion factor activator protein-1 (AP1) that is a heterodimeric 
and homodimeric protein complex with high affinity for the
nucleotide sequence TGACGTCA on inducible target genes 
(20). Transcription factors are nuclear proteins with abilities 
to specifically recognize particular core nucleotide sequences
located at the upstream or downstream on double-stranded 
DNA for modulation of the activity of RNA polymerase II 
responsible for the synthesis of mRNA from genomic DNA in 
the nucleus. Gene transcription would therefore lead to long-
lasting and sometimes permanent alterations of a variety of 
cellular functions through consolidation of transient extracel-
lular signals following regulation of de novo biosynthesis of 
inducible target proteins (21). Such consolidation mechanism 
would be operative in certain situations including neuronal 
plasticity and degeneration. 
Accumulating evidence for the expression of AP1 com-
plex in response to neuronal activities in vitro and in vivo is 
available in the literature. In primary cultures of rat cerebellar 
neurons, for example, exposure to L-glutamate (Glu) results 
in marked expression of both c-fos gene and c-Fos protein 
through activation of a particular ionotropic Glu receptor 
subtype sensitive to N-methyl-D-aspartate (NMDA), followed 
by an increase in AP1 DNA binding (22,23). Intraperitoneal 
(24) and intracerebroventricular (25) injections of NMDA 
result in the expression of c-fos mRNA and c-Fos protein in 
the rodent brain in vivo. Punching out dissection technique 
on frozen sections reveals that the systemic NMDA induces 
a rapid but transient increase in AP1 DNA binding only in the 
dentate granule layer of murine hippocampus without affecting 
that in the CA1 and CA3 pyramidal layers (26). Hippocampal 
dentate layers are shown to contain neural progenitor cells that 
spontaneously undergo proliferation and subsequent migration 
in a manner sensitive to the prevention by activation of NMDA 
receptors even in matured brain (27,28). Expression of AP1 
complex would be therefore a guidepost for the transduction 
of extracellular signals into intracellular and nuclear signals 
for long-term consolidation and amplification.
These previous studies raise the possibility that exposure 
to magnetic fields would lead to long-term consolidation as
well as amplification of different functional alterations induced
by transient extracellular signals through the modulation of 
de novo protein synthesis at the level of gene transcription in 
the brain. In this article, we will summarize our recent find-
ings on mechanisms associated with functional alterations in 
rat hippocampal neurons cultured under brief, sustained and 
repetitive exposure to static magnetic fields.
BRIEF EXPOSURE TO MAGNETISM
Several independent lines of evidence indicate that the cellular 
maturity is one of crucial determinants for the responsiveness 
to a variety of extracellular signals in neurons. In contrast to 
studies using mature cultured neurons, NMDA is often neu-
rotrophic in a manner dependent on the cellular maturity in 
cerebellar (29,30) and hippocampal (31) neurons in primary 
culture. In cerebellar slices, NMDA is more potent in depo-
larizing Purkinje and granule cells obtained from immature 
rats than those from adults rats, with similarly potent depo-
larization by agonists for other Glu receptor subtypes (32). 
Long-term potentiation (33) as well as sensitivity to Mg2+ 
block (34,35) is declined in proportion to postnatal periods 
in rat hippocampus. 
In primary cultures of rat cortical neurons cultured for 3 to 
9 DIV, no significant changes are seen in AP1 DNA binding
following the brief exposure for 15 min to static magnetic 
fields at 100 mT generated by permanent ferrite magnets
irrespective of the time after exposure up to 60 min (36). In 
immature, but not mature, cultured hippocampal neurons, 
by contrast, magnetic fields rapidly but transiently increase
AP1 DNA binding. Moreover, brief exposure almost doubles 
AP1 binding in immature hippocampal neurons plated at a 
low density with concomitant quadruplicating binding in 
those plated at a high density. Prior brief exposure to static 
magnetic fields leads to a significantly less potent increase in
AP1 DNA binding found following the addition of NMDA 
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compared to neurons not exposed to magnetism at all (36). 
Neuronal maturity could determine the responsiveness to static 
magnetic fields, which leads to long-lasting but unidentified
functional alterations through modulation of de novo synthesis 
of particular target proteins at the level of gene transcription 
by AP1 complex in the nucleus. Differential display technique 
could be useful for the search and identification of target genes
transcribed by AP1 complex that is expressed in response 
to transient magnetic stimulation as mentioned afterward in 
this article. Judging from the findings on LDH release, it is
unlikely that magnetic stimulation is neurotoxic to immature 
hippocampal neurons.
Of antibodies directed against Fos family member proteins, 
the anti-Fra-2 antibody induces a marked decrease in AP1 
binding in hippocampal neurons exposed and not exposed 
to magnetic fields with concomitant upward migration of the
mobility on the gel (Fig. 1a). Neither the anti-c-Fos nor the 
anti-Fos-B antibody markedly affects AP1 binding in hip-
pocampal neurons irrespective of the exposure to magnetic 
force. Of antibodies against Jun family member proteins, both 
the anti-c-Jun and the anti-Jun-D antibodies are effective in 
decreasing and migrating AP1 binding in hippocampal neurons 
previously exposed and not exposed to static magnetic fields.
The anti-Jun-B antibody does not markedly affect AP1 binding 
irrespective of the exposure to magnetic fields. Immunoblot-
ting analysis reveals that the brief exposure to magnetism 
results in expression of Fra-2, c-Jun and Jun-D proteins with 
the corresponding molecular weights in hippocampal neurons 
cultured at a high density when harvested 30 min after expo-
sure (Fig. 1b).
The data cited above are not sufficient to evaluate the func-
tional alterations in neurons exposed to static magnetism. For 
this purpose, we have determined the levels of intracellular 
free Ca2+ ions permeable to NMDA receptor channels using 
a Ca2+-sensitive fluorescent dye with the aid of a confocal
laser-scanning microscope. The addition of NMDA markedly 
increases the number of fluorescent cells with an increased
intracellular free Ca2+ concentration in a concentration-de-
Figure 1. Expression of AP1 complex by brief exposure to magnetism. Brief exposure to static magnetic fields for 15 min
led to marked expression of Fra2, JunD and c-Jun proteins 30 min later in rat hippocampal neurons cultured for 3 DIV. 
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pendent manner in hippocampal neurons not exposed to static 
magnetic fields as shown previously (37), while prior exposure
to magnetism induces a rightward shift of the concentration-
response curve between NMDA and fluorescence 24 h later
(Fig. 2). The increase by NMDA is not only inhibited by the 
antagonist for NMDA receptor channels dizocilpine (MK-801), 
but also prevented by the blocker of L-type voltage-sensitive 
Ca2+ channels nifedipine, with the inhibitor of Ca2+ release 
across ryanodine-sensitive Ca2+ channels from intracellular 
stores dantrolene being ineffective (38).
Transient magnetic stimulation would therefore induce 
long-lasting alterations of a variety of cellular functions 
through the modulation of de novo synthesis of particular 
inducible target proteins at the level of gene transcription by 
AP1 complex in the nucleus. For instance, prior brief expo-
sure to magnetism could lead to desensitization of NMDA 
receptor channels with respect to increases in intracellular 
free Ca2+ concentration and nuclear AP1 DNA binding in 
immature cultured hippocampal neurons. Expression profiles
of growth-associated protein-43 (GAP-43) give support to 
the immaturity of hippocampal neurons cultured for 3 DIV. 
Expression of GAP-43 is associated with the neuronal devel-
opment, axonal regeneration, synaptogenesis and plasticity 
in immature neurons but not seen in mature neurons (39). By 
contrast, static magnetic fields are shown to increase the level
of dissolved oxygen in aqueous solutions containing copper 
(II), iron (II) and heme iron (III) complexes (40), and inhibit 
the growth of particular bacteria under anaerobic conditions 
without affecting that under aerobic conditions (41). Neverthe-
less, it should be emphasized that expression of mRNA and 
immunoreactive protein is not always followed by alterations 
of different functions including recognition of particular core 
nucleotide sequence. From this point of view, determination 
of DNA binding is crucial for the direct demonstration of 
functional alterations induced by magnetism. The modulation 
could underlie transformation of transient extracellular signals 
carried by magnetism into long-lasting alterations of cellular 
functions in immature hippocampal neurons.
The mechanism underlying the differential increase by 
magnetism in AP1 DNA binding between neurons from 
hippocampus and cortex is not clear so far. Proliferation, dif-
ferentiation and/or maturation could undergo with neurons in 
these 2 separate telencephalic structures in a manner differ-
ent from each other. In cortical stem cells, a cell-cell contact 
would be critical for the fate of differentiation. Cortical stem 
cells give rise to neurons, astrocytes and oligodendrocytes in 
cultures at a high density, with almost exclusive differentia-
tion into smooth muscle at a low density (42). The fact that 
Figure 2. Desensitization 
of NMDA receptor chan-
nels by brief magnetism. 
Brief magnetism significantly
desensitized the ability of 
NMDA receptor channels 
to permeate free Ca2+ ions 
across cell membranes in 
cultured hippocampal neu-
rons when determined 24 h 
after the transient exposure 
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the exposure to static magnetic fields leads to an increase
in AP1 DNA binding in hippocampal neurons in a density-
dependent fashion could be accounted for by taking into 
consideration these previous findings. A number of adhesive
molecules would be responsible for the aforementioned 
density-dependent increase through a mechanism relevant to 
communications by intimate contacts between cells. An in 
situ hybridization study reveals that high frequency rTMS in 
vivo induces marked expression of mRNAGFAP in the murine 
hippocampal dentate gyrus with modest expression in cerebral 
cortex, as seen with electroconvulsive seizures (43). The pos-
sibility that the expression of AP1 complex by magnetism may 
be involved in mechanisms associated with clinical usefulness 
of rTMS for several psychiatric disorders, however, remains 
to be elucidated in future studies.
At any rate, the hippocampus seems to be one of the target 
architectures highly responsive to magnetism amongst dis-
crete brain structures. In murine hippocampal slices in vitro, 
for example, steady magnetic fields differentially modulate
evoked potentials at 8 to 10 mT (44). Direct current-gener-
ated magnetic fields induce biphasic effects on the population
spike recorded from murine hippocampal slices, which occurs 
in a manner sensitive to the inhibitor of calcium release from 
intracellular stores dantrolene but not to the NMDA receptor 
antagonists (45). In human hippocampus in vivo, moreover, 
the exposure to weak direct current magnetic field stimula-
tion alters the interictal epileptiform spike activity in several 
patients suffering from mesial temporal lobe epilepsy (46,47). 
Evocation of epileptiform activity is seen after the exposure 
to direct current magnetic fields of between 0.9 and 1.8 mT
in epileptic patients undergoing pre-surgical evaluation (48), 
while increased interictal firing rates are confirmed after a 
series of magnetic field periods in epileptic patients with
depth electrode implantation in hippocampus for pre-surgical 
evaluation (49).
SUSTAINED EXPOSURE TO MAGNETISM
In this section, we will summarize our recent observations on 
a gene downregulated in response to sustained exposure to 
static magnetic fields at 100 mT for a period of up to 9 DIV
in hippocampal neuronal preparations. The sustained exposure 
significantly increases the expression of immunoreactive
GFAP in hippocampal neuronal cultures, without markedly 
affecting that of GFAP and proliferating cell nuclear antigen 
(PCNA) in cultured astrocytes prepared from the rat hippo-
campus and neocortex (50). No significant cell death is found
in hippocampal and neocortical astrocytes cultured under 
sustained exposure to magnetism. By contrast, the sustained 
exposure to static magnetic fields significantly decreases the
expression of immunoreactive MAP-2 (microtubule-associated 
protein-2; a neuronal marker protein) to approximately 75% of 
the control level (Fig. 3). On immunocytochemical analysis, 
most cells are immunoreactive to MAP-2 at both cell bodies 
and neurites in cultured immature hippocampal neurons, while 
sustained exposure to magnetism leads to a marked decrease in 
MAP-2 expression at neurites rather than cell bodies. Similarly, 
sustained magnetism significantly decreases the expression of
the neuronal marker protein neuronal nucleus (NeuN) without 
significantly affecting that of GAP-43 in hippocampal neurons.
No significant cell death is seen in hippocampal neurons cul-
tured under the sustained exposure to static magnetic fields
on morphological analysis using a double fluorescent staining
with Hoechst 33342 (bis-benzimide trihydrochloride) and 
propidium iodide (PI). Moreover, sustained exposure does 
not significantly affect the cell survivability quantified by 3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
(MTT) assays in cultured hippocampal neurons. However, 
sustained magnetism induces a significant increase in the
maximal response for NMDA to increase intracellular free Ca2+ 
concentrations without significantly altering EC50 values.
The essential importance is that sustained exposure to static 
magnetic fields leads to significant potentiation of the maxi-
mal response of NMDA toward an increase in intracellular 
free Ca2+ ions without affecting the concentration for a half-
maximal response in cultured rat hippocampal neurons. The 
data from semi-quantitative reverse transcription polymerase 
chain reaction (RT-PCR) analysis give support to the idea that 
Figure 3. Expression of different marker proteins by sus-
tained magnetism. Sustained exposure to static magnetism 
resulted in a decrease in the expression of both MAP-2 
and NeuN, but not GAP-43, in cultured hippocampal 
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sustained magnetism could facilitate opening processes of 
NMDA receptor channels through upregulated expression of 
particular NMDA receptor subunits required for heteromeric 
assemblies of functional receptor channels. In fact, sustained 
magnetism results in profound upregulation of expression 
of mRNA for NR1, NR2A-C, NR2D and NR3A subunits in 
cultured hippocampal neurons, without markedly affecting 
that for GAP-43 and the housekeeping gene glycelaldehyde-
3-phosophate dehydrogenase (GAPDH) (50). Although the 
increased maximal response gives rise to the possible upregula-
tion of NMDA receptor channels, Western blotting analysis is 
needed on expression of all NMDA receptor subunits required 
for assembled functional channels when antibodies are com-
mercially available against all different NR subunits cloned 
to date. The inhibition by nifedipine (38) still maintains the 
possibility that sustained magnetism would modulate proper-
ties of voltage-sensitive Ca2+ channels. 
It should be noted that sustained magnetism increases the 
expression of the dominant negative NR3A subunit in addition 
to NR1, NR2A-C and NR2D subunits. NR3A subunit associ-
ated with NR1 and NR2 subunits is shown to decrease Ca2+ 
permeation in response to stimulation by NMDA in contrast 
to NR1/NR2 channels (51). Assembly with NR1 subunit is 
required for surface expression of functional NMDA channels 
containing NR2A and NR3A subunits (52). Coexpression of 
NR1-1a, NR2A and NR3A subunits, which would result in 
a mixed population of functional NMDA channels such as 
NR1-1a/NR2A and NR1-1a/NR2A/NR3A, facilitates the ac-
cumulation of NR3A subunit in the endoplasmic reticulum 
with less expression at the cell surface (52). The increased 
expression of mRNA for NR1, NR2A-C, NR2D and NR3A 
subunits altogether is therefore insufficient to predict the
functional alteration of NMDA channels expressed at the cell 
surface following sustained magnetism. Other NR2 subunits 
could compete for NR1 subunit required for intracellular traf-
ficking of NR3A subunit upregulated by sustained magnetism
from the endoplasmic reticulum to the cell surface. Analysis 
on the expression of each NR2 subunit is undoubtedly re-
quired for further evaluation of heteromeric channel properties 
including agonist affinity, desensitization, inactivation and
developmental expression profiles as shown with mice (53).
To our knowledge, our article for the first time deals with the
possible correlation between sustained magnetism and altered 
functionality of NMDA receptor channels in immature cultured 
rat hippocampal neurons. Sustained magnetism could induce a 
variety of functional and/or pathological alterations associated 
with the crisis of neuropsychiatric disorders through upregu-
lated NMDA receptor channels in hippocampal neurons.
Upregulation of NMDA receptors would account for the 
significant decrease in expression of MAP-2 in hippocampal
neurons cultured under sustained magnetism. Microtubules 
are components of the neuritic cytoskeletons that play an 
important role in neuronal maturation. MAP-2 is a major 
constituent of cross-bridges between microtubules in dendrites 
with the essentiality for dendritic growth through selective 
stabilization of dendritic microtubules (54), while GAP-43 is 
a marker of neuronal maturity that is associated with neuronal 
development, axonal regeneration and synaptogenesis (39). 
Two high-molecular weight isoforms (MAP-2a and MAP-
2b) with an apparent molecular weight of 280 kD and two 
low-molecular weight isoforms (MAP-2c and MAP-2d) with 
an apparent molecular weight of 70 kD are known to reside 
in the brain to date (55). Both MAP-2c and MAP-2d with a 
low-molecular weight are detected in glia as well as neurons 
(56), but MAP-2a and MAP-2b with a high-molecular weight 
are specifically expressed in neurons (57). MAP-2 is also a
likely target of transmembrane signal transduction pathways 
during several stages of neural development. Phosphorylation 
of MAP-2 occurs in a manner dependent on the subtype of 
Glu receptors involved and resultant Ca2+-dependent pathways 
(58). The systemic administration of ammonium acetate is 
shown to induce proteolysis of MAP-2 through activation 
of the Ca2+-stimulated protease calpain I after stimulation of 
NMDA receptors (59). Activation of NMDA receptors leads 
to rapid but reversible dendritic injury with concomitant 
proteolysis of MAP-2 (60-62). One possible speculation is 
that upregulated NMDA receptors may play a pivotal role in 
mechanisms underlying the significant decrease in MAP-2
expression in hippocampal neurons cultured under sustained 
magnetism. The exact mechanism as well as functional 
significance of modulation by NMDA receptors, however,
remains to be elucidated in future studies. The evaluation on 
the number of living cells gives rise to an idea that sustained 
magnetism would modulate expression of MAP-2 or GFAP 
without affecting cellular viability and proliferation in cultured 
hippocampal preparations. 
There is accumulating evidence that expression of MAP-2 
may be a useful marker for diagnosis of schizophrenia and 
bipolar disorder in vivo (63,64) and in vitro (65,66). Altered 
expression of GFAP is also seen in postmortem evaluation 
of brains from patients with schizophrenia, bipolar disorder 
and major depressive disorder (67,68). An in situ hybridiza-
tion study reveals that high frequency rTMS in vivo induces 
increased expression of mRNAGFAP in the murine hippocampal 
dentate gyrus with modest expression in neocortex, as seen 
with electroconvulsive seizures (43). On both in situ hybrid-
ization and immunohistochemistry analyses, however, rTMS 
induces expression of immediately early genes such as c-fos 
with a profile different from that seen after electroconvulsive
stimulation in rat brain (69). The possibility that the present 
alterations of expression of both MAP-2 and GFAP under sus-
tained magnetism may be involved in mechanisms associated 
with the crisis of a variety of psychiatric disorders sensitive 
to the treatment with rTMS, thus, is not ruled out. Altered 
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expression of NMDA receptors would at least in part underlie 
the clinical usefulness of rTMS, whereas our data suggest that 
static magnetic stimulation is not toxic to both neurons and 
astrocytes in terms of cellular survivability.
Moreover, hippocampal neurons cultured under sustained 
exposure to static magnetic fields are subjected to extraction of
total RNA for differential display (DD) analysis using random 
primers (Fig. 4a) (70). Differentially expressed genes by sus-
tained exposure to static magnetic fields are used as templates
for PCR re-amplification (Fig. 4b), while the purified PCR
products are subsequently cloned into pT7 blue plasmid and 
sequenced to search for DNA sequence similarity with the 
BLASTN algorithm. As a consequence of the study described 
above, two particular genes are found to be downregulated 
in response to sustained magnetism in hippocampal neurons. 
The two cloned differentially expressed fragments are labeled 
with [α-32P]dCTP for Northern blot analysis. Expression of 
mRNA for #812 is significantly decreased during in vitro 
cultivation of hippocampal neurons, while a further decrease 
is seen in expression of mRNA for #812 and #612 in hippo-
campal neurons cultured under sustained exposure to static 
magnetic fields at 100 mT (Fig. 4c). Cloning of the genes
reveals sequences highly homologous (95% identical) to the 
3’ non-coding regions of the mouse basic helix-loop-helix 
(bHLH) transcription factor ALF1 (#812) and that of histone 
H3.3A (#612), respectively (Fig. 4d). 
The gene, m use ALF1 gene (accession number X64840), 
is a murine analogue to the class I bHLH protein, HEB/HTF. 
bHLH proteins are shown to bind as homo- or hetero-dimer 
to the consensus DNA sequence CANNTG, known as E-box, 
with categorization into several classes on the basis of distri-
bution profiles, dimerization capabilities and DNA binding
Figure 4. Downregulation of particular genes by sustained magnetism. Sustained magnetism downregulated two differ-
ent genes in hippocampal neurons cultured for 3 DIV as revealed by DD-PCR (a), 1st DD-PCR (b), 2nd amplification (c), 
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specificities (71). A class I bHLH factor termed as E-factor,
which includes E12, E47, HEB/HTF4 and E2-2, is ubiquitously 
expressed (72) and able to dimerize with tissue-specific class II
factors such as MyoD in skeletal muscle (73) and Neurogenin 
in neural tissue (74), to regulate cell-specific gene transcrip-
tion. The activity of these factors is often negatively regulated 
by another class of HLH protein lacking basic domain includ-
ing the dominant-negative/inhibitory Id. Expression of the 
E-factor gene ALF1 is regulated during trophoblast develop-
ment, as the expression is extinguished in advance of giant cell 
differentiation (75). In Schwann cells, discordance is seen for 
ALF1 expression between protein and transcript levels, with 
protein levels being sharply down-regulated in terminally dif-
ferentiated cells which continue to express abundant mRNA 
(76). In the developing central nervous system, E-factor gene is 
expressed in proliferating neuroblasts and neurons at the initial 
stages of differentiation with the absence from matured and 
differentiated cells (77-79). Reduced expression of the E-fac-
tor gene ALF1 mRNA could be at least in part responsible for 
mechanisms underlying alterations of cellular differentiation 
and maturation, but not for proliferation and survival, during 
sustained exposure to static magnetic fields.
REPETITIVE EXPOSURE TO MAGNETISM
As mentioned above, rTMS is shown to be beneficial for the
treatment and therapy of selected patients with depression, 
bipolar affective disorder and schizophrenia as a possible 
alternative to ECT often used for the treatment of refractory 
depression (14-16). This fact implies the importance of subse-
quent evaluation on the functionality in hippocampal neurons 
cultured under the repetitive exposure to static magnetic fields.
Hippocampal neurons are thus cultured under daily brief 
exposure to static magnetic fields at 100 mT for 15 min each
day for the consecutive 8 DIV, followed by cell harvest 24 h 
after the last exposure and subsequent determination of cell 
viability and expression of different proteins on Western blot 
analysis. No marked alterations are found for the morphology 
(Fig. 5a, left) and survivability (Fig. 5a, right) in hippocampal 
neurons cultured under daily repetitive exposure to static mag-
netic fields. However, the repetitive exposure to static mag-
netic fields significantly decreases by 50% the expression of
MAP-2 with different molecular weights that are individually 
increased in proportion to cellular maturation (Fig. 5c), without 
significantly affecting that of NeuN and GAP-43 (Fig. 5b). By
contrast, no significant changes are seen in the expression of
both GFAP and PCNA in hippocampal preparations cultured 
under daily repetitive exposure to static magnetic fields (Fig.
5b). Daily repetitive magnetism is found to be effective in 
significantly increasing the expression of NR2B subunit, but
not that of NR2A subunit. Repetitive magnetism fails to alter 
the expression of NR1 subunit essential for the assembly of 
functional NMDA receptor channels. The cumulative addi-
tion of NMDA significantly increases Ca2+ fluorescence in a
concentration-dependent manner at a concentration range of 1 
to 100 µM in hippocampal neurons, while daily repetitive mag-
netism induces a leftward shift of the concentration-response 
curve without significantly affecting the maximal response.
Since rTMS elicits beneficial and therapeutic effects on
different neuropsychiatric disorders including refractory de-
pression, an analysis is required for the possibility that daily 
repetitive magnetism is really protective against a variety of 
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rat ALF1:  ggtgtttgcagc tatca tctgctgtaagcaatgtgtcgcttctgcacaatcagagac
mouse ALF1:2411 aggtgtttgcagcatatcactctgctgtaatcagtgtgtcgcttctgcacaatcagagac 2470
rat ALF1: tgtctcatctctccactcaccgtggaagttgccttgtgcctaaactgaattgacaaatgc
mouse ALF1:2471 tgtctcatctctc-actcaacgtggaagttgccttgtgcctaaactgaattgacaaatgc 2529
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Figure 5. Repetitive magnetism. Daily repetitive magnetism markedly affected neither cellular survivability (a), nor expres-
sion of the neuronal marker protein NeuN, the neurite growth marker protein GAP-43, the astroglial marker protein GFAP 
and the proliferation marker protein PCNA (b), but led to significant downregulation of the expression of MAP-2 with 2
different molecular weights (c), in hippocampal neurons cultured for 8 DIV. 
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damages in cultured neurons. For this purpose, hippocampal 
neurons are cultured in the presence of the NMDA antagonist 
MK-801 at different concentrations. The antagonist MK-801 
not only decreases cell survivability in a concentration-depen-
dent manner at a concentration range of 1 to 100 µM in cultured 
hippocampal neurons, but also inhibits the expression of MAP-
2 with two different molecular weights, 70 kD and 280 kD. 
Almost complete inhibition is seen for the endogenous level 
of MAP-2 with both molecular weights in neurons cultured in 
the presence of 100 µM MK-801. Moreover, semi-quantitative 
RT-PCR analysis reveals that a significant decrease is seen in
the expression of mRNA for both GAP-43 and brain-derived 
neurotrophic factor in hippocampal neurons cultured in the 
presence of 10 µM MK-801. Similarly, MK-801 significantly
decreases the endogenous level of NR1 subunit by more than 
50% with a concomitant increase in that of NR2A subunit when 
exposed to hippocampal neurons for a consecutive period. 
These data are suggestive of the neurotoxicity of MK-801 in 
cultured hippocampal neurons. 
Daily repetitive magnetism is ineffective in preventing the 
loss of NR1 subunit by MK-801, but more than doubles the 
increased expression of NR2A subunit in neurons cultured 
in the presence of MK-801 without significantly altering
the expression in the absence of MK-801. The expression of 
NR2B subunit is significantly increased in neurons cultured
under daily repetitive magnetism as described above, while 
in neurons cultured in the presence of MK-801 daily re-
petitive magnetism fails to increase the expression of NR2B 
subunit. As a guidepost to evaluate the activity of NMDA 
receptor channels, the intracellular free Ca2+ concentration 
is determined by fluo-3 fluorescence using confocal laser
microscopy. The cumulative addition of NMDA increases the 
fluorescence intensity in a concentration-dependent manner at
a concentration range of 1 to 100 µM in the absence of added 
Mg2+ ions in hippocampal neurons, while in neurons cultured 
in the presence of 10 µM MK-801 significant decreases are
seen in the maximal response and the sensitivity to NMDA. 
Daily repetitive magnetism is found to significantly protect
against the decreased sensitivity to NMDA without affecting 
the maximal response. Although both daily repetitive magne-
tism and sustained exposure to MK-801 induce a significant
decrease in the endogenous level of MAP-2 with two differ-
ent molecular weights as mentioned above, daily repetitive 
magnetism significantly prevents the decrease of MAP-2 with
different molecular weights in hippocampal neurons cultured 
in the presence of MK-801. In neurons cultured under daily 
repetitive magnetism, sustained exposure to MK-801 fails to 
further decrease the expression of MAP-2. 
The data cited above argue in favor of an idea that repetitive 
magnetism would be protective against abnormalities and/or 
malfunctions in hippocampal neurons cultured in the sus-
tained presence of the NMDA receptor antagonist MK-801. 
Overstimulation of NMDA receptors is well known to induce 
neurotoxicity through massive influx of extracellular Ca2+ ions 
across the cation channels, whereas blockade of NMDA recep-
tors would also lead to neurotoxicity, such as vacuolization in 
rat (80) and mouse (81) brains, with behavioral abnormalities 
related to psychosis. Moreover, widespread apoptotic neurode-
generation would be brought about by the transient blockade of 
NMDA receptors for only a few hours during the late fetal or 
early neonatal period in developing rat brain (82). In contrast 
to fatal NR1 null mice, mice with reduced expression of NR1 
subunit survive to adulthood with concomitant exhibition of a 
variety of psychotomimetic abnormal behaviors that are ame-
liorated by treatment with the antipsychotic drugs haloperidol 
and clozapine (83). These previous findings all give support
to the toxicity related to psychosis by sustained blockade of 
NMDA receptor channels in cultured rat hippocampal neurons 
irrespective of the cell maturity as described in this article. In 
a quantitative postmortem study on brains of patients with 
sporadic bipolar disorder, in fact, a significant decrease is
seen in expression of both MAP-2 and MAP-1b, in addition to 
laminar thickness and neuron densities, in layers III, V and VI 
of the subgenual part of area 24 (66). Immunoreactive MAP-2 
is significantly decreased in cortical layers III and V in areas 9
and 32 of the prefrontal cortex, but not in the occipital cortex, 
in brains of patients suffering from schizophrenia (84). In situ 
hybridization analysis reveals that in rat brain a significant
increase is seen in the expression of mRNAMAP-2 in the dentate 
gyrus within 24 h after the last trial of daily repetitive electro-
convulsive shock that is an animal model of ECT in clinical 
treatment of depression (85). The fact that sustained exposure 
to MK-801 led to a marked decrease in the endogenous level 
of MAP-2 in cultured hippocampal neurons, gives rise to the 
similarity between phenomena found in in vivo clinical cases 
and in vitro cultured neurons in terms of the decreased MAP-
2 level. The present experimental procedures would give a 
clue for the elucidation of mechanisms underlying the clinical 
usefulness of rTMS for the therapy of refractory depression, 
schizophrenia, Parkinson’s disease and Alzheimer’s disease in 
human subjects. The possibility that molecular mechanisms 
would at least in part involve different phenomena mentioned 
in this review with respect to the etiology and pathology of cri-
sis of a variety of symptoms relevant to those neuropsychiatric 
and neurodegenerative disorders is not ruled out. 
CONCLUSION
The findings cited above argue in favor of an idea that static
magnetic fields would at first induce particular immediately
early genes, such as c-fos and c-jun, for modulation of the 
expression of target genes responsible for the homeostatic 
maintenance of the functionality and integrity in neurons. 
For example, brief exposure to static magnetism could de-
crease the endogenous level of MAP-2 required for matured 
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neuritic cytoskeletons through rapid expression of the nuclear 
transcription factor AP1 complex consisting of c-Jun, JunD 
and/or Fra2 proteins and subsequent attenuation of opening 
processes of NMDA receptor channels permeable to calcium 
ions in hippocampal neurons as shown in Fig. 6. Similarly, 
the bHLH transcription factor ALF1 identified on DD analy-
sis could at least in part play a role in mechanisms related to 
the decreased expression of MAP-2 in hippocampal neurons 
cultured under sustained exposure to static magnetic fields.
By contrast, repetitive magnetism seems to be useful for the 
prevention of neurotoxicity of an NMDA receptor channel 
antagonist in terms of the endogenous level of MAP-2 in 
cultured hippocampal neurons. In addition to the aforemen-
tioned in vitro studies using cultured neurons, further in vivo 
studies are undoubtedly required for the demonstration of 
modulating properties of static magnetic fields on a variety
of neuronal activities. 
It thus appears that static magnetic fields really modu-
late the neuronal activity through regulation of the gene 
expression in cultured rat hippocampal neurons. The altered 
MAP-2 expression is suggestive of rather potent functional 
alterations in response to static magnetic fields under differ-
ent exposure conditions. The magnetic modulation would be 
at least in part responsible for the high incidence of different 
neuropsychiatric disorders in regions with a higher magnetic 
density, in addition to less sunshine, than other areas on this 
globe. Much attention may need to be paid to the clinical use 
of powerful magnetic generators such as magnetic resonance 
image and nuclear magnetic resonance for the diagnosis of a 
variety of disorders associated with brain malfunctions. Both 
electromagnetic induction and physical force generation could 
affect the signal conduction mediated by axonal local electric 
circuitry to lead to altered transmission mediated by exocytotic 
release of neurotransmitters at synapses in central neurons. 
Elucidation of the exact underlying molecular mechanisms 
would give us a clue for the discovery and development of 
novel strategies useful for the therapy and treatment in patients 
suffering from a variety of neuropsychiatric and neurodegen-
erative disorders. 
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